Back
ProShares Ultra Gold Vs. Novartis AG Industry Stock Comparison
Buy
76
UGL
ProShares Ultra Gold
Last Price:
$117.69
Seasonality Move:
1.47%
Buy
64
NVSEF
Novartis AG
Last Price:
$109.00
Seasonality Move:
5.79%
Buy
76
ProShares Ultra Gold (UGL)
is a Buy
Is ProShares Ultra Gold a Buy, Sell or Hold?
-
The current ProShares Ultra Gold [UGL] share price is $117.97. The Score for UGL is 76, which is 52% above its historic median score of 50, and infers lower risk than normal.
-
UGL is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
64
Novartis AG (NVSEF)
is a Buy
Is Novartis AG a Buy, Sell or Hold?
-
The current Novartis AG [NVSEF] share price is $109.00. The Score for NVSEF is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
-
NVSEF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
UGL Stock Price Chart
What is ProShares Ultra Gold's stock price today?
-
The ProShares Ultra Gold share price today is $117.97Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UGL is experiencing buying pressure, which is a positive indicator for future bullish movement.
NVSEF Stock Price Chart
What is Novartis AG's stock price today?
-
The Novartis AG share price today is $109.00The current trend is moderately bearish and NVSEF is experiencing slight buying pressure.
UGL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2 | Buy |
Relative Strength Index (14 RSI): | 65.01 | Buy |
Chaikin Money Flow: | 315896 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (110.2 - 114.84) | Buy |
Bollinger Bands (100): | (94.34 - 109.26) | Buy |
NVSEF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.31 | Buy |
Relative Strength Index (14 RSI): | 49.51 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (104.92 - 112.32) | Buy |
Bollinger Bands (100): | (98.63 - 109.33) | Buy |
UGL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 113.09 | Buy |
20-day SMA: | 112.95 | Buy |
50-day SMA: | 106.07 | Buy |
200-day SMA: | 93.43 | Buy |
8-day EMA: | 113.68 | Buy |
20-day EMA: | 112.06 | Buy |
50-day EMA: | 107.63 | Buy |
200-day EMA: | 94.6 | Buy |
NVSEF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 112.13 | Sell |
20-day SMA: | 109.59 | Sell |
50-day SMA: | 103.95 | Buy |
200-day SMA: | 106.34 | Buy |
8-day EMA: | 111.45 | Sell |
20-day EMA: | 109.6 | Sell |
50-day EMA: | 106.3 | Buy |
200-day EMA: | 104.26 | Buy |
ProShares Ultra Gold Earnings Growth & UGL Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Novartis AG Earnings Growth & NVSEF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
ProShares Ultra Gold Technical Analysis
Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novartis AG Technical Analysis
Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |